• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一个风险评估问卷,以协助在普通人群中进行丙型肝炎筛查。

Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.

机构信息

Cluster Infectious Diseases, Department of Research, Amsterdam Public Health Service, Amsterdam, the Netherlands.

出版信息

Euro Surveill. 2010 Apr 15;15(15):19539.

PMID:20429995
Abstract

Many individuals with hepatitis C virus (HCV) infection are undiagnosed. This study evaluates a risk assessment questionnaire, developed for use online to target blood-screening for HCV. Two hundred and eighty-nine patients with known HCV status completed a written questionnaire on prominent HCV risk factors. Questionnaires generated advice to seek testing if at least one risk factor was reported. Agreement of the testing advice with the HCV status of respondents was evaluated. Subsequently, we validated our questionnaire among 985 patients of an outpatient clinic for sexually transmitted infections. The post-test-probability-of-disease (PTPD) and diagnostic gain (PTPD minus prior probability of disease) were calculated. The questionnaire's sensitivity and specificity were 84.6% and 63.8%, respectively, and higher in the STI clinic patients. The PTPD of positive testing advice was 72.5% given HCV prevalence of 53.0%, yielding a diagnostic gain of 19.5%. Applying the estimated prevalence in the general Dutch population (0.1-0.4%), and the anticipated prevalence in the online project (1.0-6.0%), yielded diagnostic gains of 0.13-0.53% and 1.3-7.0%, respectively. We conclude that our questionnaire succeeded in selecting at-risk individuals as its testing advice agreed well with the HCV status. We suggest that the questionnaire be used online as a selection tool for HCV blood-screening in the general population.

摘要

许多丙型肝炎病毒 (HCV) 感染者未被诊断出来。本研究评估了一种风险评估问卷,该问卷专为在线使用而开发,旨在针对 HCV 进行血液筛查。289 名已知 HCV 感染者完成了一份关于 HCV 主要危险因素的书面问卷。如果报告了至少一个危险因素,则问卷会提供进行检测的建议。评估了测试建议与受访者 HCV 状况的一致性。随后,我们在性传播感染门诊的 985 名患者中验证了我们的问卷。计算了疾病后验概率 (PTPD) 和诊断增益 (PTPD 减去疾病先验概率)。问卷的灵敏度和特异性分别为 84.6%和 63.8%,在性传播感染门诊患者中更高。阳性检测建议的 PTPD 为 72.5%,HCV 流行率为 53.0%,诊断增益为 19.5%。应用一般荷兰人群中的估计患病率 (0.1-0.4%) 和在线项目中的预期患病率 (1.0-6.0%),分别产生 0.13-0.53%和 1.3-7.0%的诊断增益。我们得出结论,我们的问卷成功地选择了处于风险中的个体,因为其测试建议与 HCV 状况非常吻合。我们建议在线使用问卷作为一般人群 HCV 血液筛查的选择工具。

相似文献

1
Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.评估一个风险评估问卷,以协助在普通人群中进行丙型肝炎筛查。
Euro Surveill. 2010 Apr 15;15(15):19539.
2
Using mass media and the Internet as tools to diagnose hepatitis C infections in the general population.利用大众媒体和互联网作为工具,对普通人群中的丙型肝炎感染进行诊断。
Am J Prev Med. 2011 Mar;40(3):345-52. doi: 10.1016/j.amepre.2010.11.019.
3
Description of a new hepatitis C risk assessment tool.一种新型丙型肝炎风险评估工具的描述。
Arch Intern Med. 2005 Sep 26;165(17):2013-8. doi: 10.1001/archinte.165.17.2013.
4
Validation of a hepatitis C screening tool in primary care.丙型肝炎初级保健筛查工具的验证
Arch Intern Med. 2008 Oct 13;168(18):2009-13. doi: 10.1001/archinte.168.18.2009.
5
Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.泰国献血者中的丙型肝炎病毒感染:抗体流行率、危险因素及风险筛查表的制定
Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):147-54.
6
Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).丙型肝炎病毒马赛克风险评分的开发与验证,以辅助对男男性行为者(MSM)感染艾滋病毒者进行急性丙型肝炎病毒(HCV)感染检测。
Euro Surveill. 2017 May 25;22(21). doi: 10.2807/1560-7917.ES.2017.22.21.30540.
7
Outcome of screening for hepatitis C virus infection based on risk factors.基于风险因素的丙型肝炎病毒感染筛查结果
Am J Gastroenterol. 2008 Jan;103(1):131-7. doi: 10.1111/j.1572-0241.2007.01522.x. Epub 2007 Sep 25.
8
Point-of-care testing for HCV infection: recent advances and implications for alternative screening.丙型肝炎病毒感染的即时检测:最新进展及对替代筛查的影响
New Microbiol. 2014 Oct;37(4):449-57. Epub 2014 Oct 1.
9
Hepatitis C virus (HCV): prevalence in a gynecological urgent care clinic population.丙型肝炎病毒(HCV):在妇科急诊诊所人群中的患病率
Infect Dis Obstet Gynecol. 2004;12(1):9-12. doi: 10.1080/1064744042000210393.
10
Examining hepatitis C virus testing practices in primary care clinics.检测初级保健诊所中的丙型肝炎病毒检测实践。
J Viral Hepat. 2012 Feb;19(2):e163-9. doi: 10.1111/j.1365-2893.2011.01539.x. Epub 2011 Nov 17.

引用本文的文献

1
Relationship of hepatitis C risk to hepatitis C test acceptance among adult patients participating in an ED hepatitis C screening programme.参与 ED 丙肝筛查项目的成年患者中丙型肝炎风险与丙型肝炎检测接受率的关系。
Emerg Med J. 2023 May;40(5):341-346. doi: 10.1136/emermed-2022-212726. Epub 2023 Jan 2.
2
Hepatitis B, C and human immunodeficiency virus knowledge among the general greek population: results from the Hprolipsis nationwide survey.希腊普通人群的乙型肝炎、丙型肝炎和人类免疫缺陷病毒知识:来自全国 Hprolipsis 调查的结果。
BMC Public Health. 2022 Nov 5;22(1):2026. doi: 10.1186/s12889-022-14353-9.
3
Risk factors for HCV transmission in HIV-positive men who have sex with men in México.
墨西哥男男性行为 HIV 阳性者中丙型肝炎病毒传播的风险因素。
PLoS One. 2022 Jul 15;17(7):e0269977. doi: 10.1371/journal.pone.0269977. eCollection 2022.
4
An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.一种适用于普通人群中靶向丙型肝炎病毒检测的易于实施的风险评分。
Microbiol Spectr. 2022 Apr 27;10(2):e0228621. doi: 10.1128/spectrum.02286-21. Epub 2022 Mar 31.
5
Performance and modification of EGCRISC among hepatitis C virus high-risk groups.丙型肝炎病毒高危人群中 EGCRISC 的表现和修饰。
Epidemiol Infect. 2020 Feb 14;148:e28. doi: 10.1017/S0950268820000175.
6
Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests.中东和北非地区丙型肝炎病毒检测对象是谁?:对2500项患病率测量值(包括4900万次检测)的汇总分析
Hepatol Commun. 2019 Jan 23;3(3):325-339. doi: 10.1002/hep4.1310. eCollection 2019 Mar.
7
Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?丙型肝炎风险群体检测策略是否达到目标?
Front Pharmacol. 2017 Jun 30;8:437. doi: 10.3389/fphar.2017.00437. eCollection 2017.
8
Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).丙型肝炎病毒马赛克风险评分的开发与验证,以辅助对男男性行为者(MSM)感染艾滋病毒者进行急性丙型肝炎病毒(HCV)感染检测。
Euro Surveill. 2017 May 25;22(21). doi: 10.2807/1560-7917.ES.2017.22.21.30540.
9
Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.EGCRISC在埃及人群慢性丙型肝炎感染筛查及风险评估中的验证
PLoS One. 2016 Dec 21;11(12):e0168649. doi: 10.1371/journal.pone.0168649. eCollection 2016.
10
Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand.新西兰达尼丁中年人群丙型肝炎的患病率及知晓情况
World J Gastroenterol. 2015 Sep 21;21(35):10224-33. doi: 10.3748/wjg.v21.i35.10224.